Advances in Collaborative Practice for Patients With Head and Neck Cancers

November 5, 2016

Learning Objectives

  • Demonstrate increased understanding of the mechanisms of tumor immune escape and their role in cancer disease progression as well as the mechanisms of action (MOAs) of immunotherapy used in the treatment of HNSCC.
  • Monitor for and manage adverse effects of immune checkpoint inhibitor therapy and EGFR-directed therapy in the treatment of patients with recurrent or metastatic HNSCC.
Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/05/2016
Course expires: 
06/08/2017
Event starts: 
11/05/2016 - 9:10am
Event ends: 
11/05/2016 - 10:10am
Cost:
$0.00
Rating: 
0
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.